{
    "paper_id": "PMC7202245",
    "metadata": {
        "title": "Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using\nLanthanide-Doped Nanoparticles-Based Lateral Flow\nImmunoassay",
        "authors": [
            {
                "first": "Zhenhua",
                "middle": [],
                "last": "Chen",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Zhigao",
                "middle": [],
                "last": "Zhang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Xiangming",
                "middle": [],
                "last": "Zhai",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yongyin",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Li",
                "middle": [],
                "last": "Lin",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Hui",
                "middle": [],
                "last": "Zhao",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Lun",
                "middle": [],
                "last": "Bian",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Peng",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Lei",
                "middle": [],
                "last": "Yu",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yingsong",
                "middle": [],
                "last": "Wu",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Guanfeng",
                "middle": [],
                "last": "Lin",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Tris(1,3-diphenyl-1,3-propanedionato)(1,10-phenanthroline)europium(III)\n(Eu(DPP)3Phen), styrene (St), acrylic acid (AA),\n2,2\u2032-azobis(isobutyronitrile) (AIBN), and\ncetyltrimethylammonium (CTMA) were purchased from Tokyo Chemical\nIndustry Co. (Tokyo, Japan). 2-(N-morpholino)\nethanesulfonic acid (MES), surfactant (including polyvinylpyrrolidone\n(PVP) and TritonX-100), carboxyl activating agents (including\n1-ethyl-3-(3-(dimethylamino)propyl) carbodimide hydrochloride (EDC)\nand N-hydroxy-sulfosuccinimide (sulfo-NHS)), and\nProclin-300 were obtained from Sigma\u2013Aldrich (St. Louis, MO,\nUSA). Functional block polymer, Tetronic 1307 (surfactant S9), was\nobtained from BASF Corp. (Florham Park, NJ, USA). Rabbit IgG and goat\nanti-rabbit IgG were purchased from Rockland Immunochemicals\n(Limerick, PA, USA). Mouse anti-human IgG was obtained from Abcam\n(Cambridge, MA, USA). Nitrocellulose (NC) membranes, glass fiber\nconjugate pads, and cellulosic absorbent pads were purchased from\nMillipore (Hong Kong, China). Cellulosic sample pads were from Jieyi\nBiotechnology Co., Ltd. (Shanghai, China). Bovine serum albumin (BSA)\nwas obtained from Roche Diagnostics (Hong Kong, China). Other\nchemicals used in this study were of analytic grade and used without\nfurther treatment. Ultrapure water, obtained using a Milli-Q Advantage\nA10 purification system (Millipore), was used in all experiments.",
            "cite_spans": [],
            "section": "Reagents, Samples, and Instrumentation ::: Experiment",
            "ref_spans": []
        },
        {
            "text": "The following buffer solutions were used: coating buffer (0.3% trehalose\n[w/v] and 0.1% NaN3 [w/v] in 100 mM citrate-buffered saline\n[CBS], pH 8.5); sample pad treatment buffer (100 mM\nNa2B4O7\u00b710H2O,\n1% PVP [w/v], 0.2% casein-Na [w/v], 1% TritonX-100 [v/v], and 0.1%\nNaN3 [w/v]); conjugate pad treatment buffer (0.5%\npoly(vinyl alcohol) [PVA] [w/v], 0.5% BSA [w/v], and 1% TritonX-100\n[v/v] in 50 mM phosphate buffer, pH 7.4); activating buffer (50 mM\nMES, pH 5.1); binding buffer (10 mM phosphate buffer, pH 7.0); washing\nbuffer (0.2% Tween-20 [v/v], 0.9% NaCl [w/v], and 0.05% Proclin-300\n[v/v] in 25 mM Tris-HCl, pH 7.8); storage buffer (1% BSA [w/v], 5%\ntrehalose [w/v], 20% sucrose [w/v],and 0.05% Proclin-300 [v/v] in 25\nmM Tris-HCl, pH 9.0); and assay buffer (7.5% BSA [w/v], 0.3%\nTritonX-100 [v/v], and 0.1% surfactant S9 [w/v] in 10 mM PBS, pH 7.4).\nAll solutions in this study were freshly prepared before use.",
            "cite_spans": [],
            "section": "Reagents, Samples, and Instrumentation ::: Experiment",
            "ref_spans": []
        },
        {
            "text": "Serum samples were obtained from Guangzhou Eighth People\u2019s\nHospital and Nanfang Hospital and stored at \u221220 \u00b0C until\nuse. This study was approved by the Ethics Committee of the Science\nand Technology Department of Southern Medical University (Guangzhou,\nChina).",
            "cite_spans": [],
            "section": "Reagents, Samples, and Instrumentation ::: Experiment",
            "ref_spans": []
        },
        {
            "text": "The RNA genome of SARS-CoV-2 was kindly provided by DAAN Gene Co.\n(Guangzhou, China). Reverse transcription was performed to generate\ncDNA using PrimeScript II first Strand cDNA Synthesis Kit (Takara Bio,\nOtsu, Japan; Catalog No. 6210A). The full-length nucleocapsid\nphosphoprotein gene was amplified from the cDNA by PCR using the\nfollowing primers: 5\u2032-ATG TCT GAT AAT GGA CCC CAA AAT\nC-3\u2032 (forward) and 5\u2032-TTA GGC CTG AGT TGA GTC AGC\n\u22123\u2032 (reverse), which were designed based on sequences in\nGenBank (MN908947.3). PCR products were sequenced and cloned into the\npMD-19T backbone vector; the resultant pMD-19T-N plasmid was fused\nwith the linear pET-32a vector (Not I), using a Seamless Cloning and\nAssembly Kit (Beijing Zoman Biotechnology, Beijing, China; Catalog No.\nZC231), from which the nucleocapsid phosphoprotein gene was amplified\nusing the primers 5\u2032-AG CTC CGT CGA CAA GCT TGC ATG TCT GAT AAT\nGGA CCC CAA AAT-3\u2032 (forward) and 5\u2032-TG GTG GTG GTG GTG\nCTC GAG TGC GGC CGC GGC CTG AGT TGA GTC AGC ACT-3\u2032 (reverse).\nThe target protein was expressed in Escherichia coli\nBL21 competent cells by induction with isopropyl\n\u03b2-d-1-thiogalactopyranoside, with the induction time\noptimized to ensure maximal expression. Positive serum samples were\nused to confirm the antigenicity of the purified recombinant protein\nby Western blotting.",
            "cite_spans": [],
            "section": "Expression of Recombinant SARS-CoV-2 Nucleocapsid\nPhosphoprotein ::: Experiment",
            "ref_spans": []
        },
        {
            "text": "The LNPs were synthesized by miniemulsion polymerization. Briefly, 200 mg\nof Eu(DPP)3Phen and 20 mg of AIBN were dissolved in 2 g of\nSt in a glass vial; and 60 mg of CTMA and 100 mg of AA were dissolved\nin 15 mL of deionized water. The aqueous and monomer solutions were\nmixed with a magnetic stirrer for 10 min and miniemulsions were\nprepared with an ultrasonicator for 20 min in an ice bath. Nitrogen\ngas was bubbled for 2 h at room temperature to remove oxygen from the\nmixture, and the emulsion was then stirred at room temperature for 20\nh. The product was ultrasonically washed 4 times with water and\ncentrifuged. The resultant LNPs were dispersed in water (5% w/v) and\nstored as stock at 4 \u00b0C.",
            "cite_spans": [],
            "section": "Preparation of LNPs ::: Experiment",
            "ref_spans": []
        },
        {
            "text": "LNPs were functionalized with mouse anti-human IgG antibody (M-HIgG) and\nrabbit IgG (RIgG) as previously described,20 with\nsome modifications. A two-step procedure was used to prevent\naggregating between LNPs via cross-linking of antibody molecules.\nBriefly, 20 \u03bcL of EDC (1% EDC [w/v] in activating buffer) and\n180 \u03bcL of sulfo-NHS (1% sulfo-NHS [w/v] in activating buffer)\nsolutions were mixed and added to 2 mg of LNPs resuspended in 0.8 mL\nof activating buffer. The mixture was incubated for 30 min with gentle\nstirring at room temperature. To remove unreacted components, the LNPs\nwas washed three times by centrifugation at 18000g\nfor 10 min with binding buffer after NHS-ester was formed. The pellet\nwas ultrasonically resuspended in 0.95 mL of binding buffer. The\nantibodies were purified and diluted in binding buffer at a\nconcentration of 1 mg/mL; 50 \u03bcL of as-prepared antibody solution\n(M-HIgG or RIgG) was added into the activated LNPs suspension. A 4-h\nincubation with gentle rotation was applied, then 1.5 \u03bcL of\nethanolamine was added and the admixture was further incubated for 10\nmin. In order to purify the functionalized LNPs, the washing process\nwas repeated three times before adding blocking buffer (2% BSA in 25\nmM phosphate buffer, pH 7.4). The functionalized LNPs were\nultrasonically resuspended in blocking buffer, and a 30-min incubation\nwith gentle mixing was employed to block any remaining unreacted\nhydrophobic sites on the surface of LNPs and to form a thin hydration\nlayer to prevent aggregation. The antibody-enameled LNPs were cleansed\nthree times with washing buffer and were resuspended in storage\nbuffer.",
            "cite_spans": [
                {
                    "start": 115,
                    "end": 117,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                }
            ],
            "section": "Functionalizing LNPs with Protein Molecules ::: Experiment",
            "ref_spans": []
        },
        {
            "text": "LFIA strips were prepared as described in our previous work.21 The sample pad was immersed in a sample pad\ntreatment buffer for 1 h and dried at 37 \u00b0C for 24 h. The\nconjugate pad was saturated with a conjugate pad treatment buffer at\nroom temperature for 1.5 h and also dried at 37 \u00b0C for 24 h.\nM-HIgG@LNPs and RIgG@LNPs were diluted in storage buffer (0.125 and\n0.05 mg/mL, respectively) and combined; the mixture was dispensed onto\nthe conjugate pad at 1 \u03bcL/cm using a Biolet Quanti dispenser\n(BioDot, Shanghai, China), and dried at 37 \u00b0C before being stored\nin a dry cabinet at room temperature until use. Recombinant\nnucleocapsid phosphoprotein and goat anti-rabbit IgG were diluted with\ncoating buffer at concentration of 2 mg/mL, then dispensed onto an NC\nmembrane (Millipore; Catalog No. HF13502XSS) at 1 and 0.8 \u03bcL/cm,\nrespectively, as test and control lines. The membrane was dried at 37\n\u00b0C for 4 h. The NC membrane, absorbent pad, conjugate pad and\nsample pad were sequentially laminated together onto a backing card,\nas shown in Figure 1. Strips\nwith 4 mm wide were cut and placed into disposable plastic housings\nfor later use. The assembled test strips were stored in a\nmoisture-proof cabinet.",
            "cite_spans": [
                {
                    "start": 60,
                    "end": 62,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                }
            ],
            "section": "Fabrication of LFIA Strips ::: Experiment",
            "ref_spans": [
                {
                    "start": 1040,
                    "end": 1048,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "As shown in Figure 1, serum\nsamples were diluted with assay buffer (1:1000), and 100 \u03bcL of\ndiluted sample was added to the sample well of a LFIA strip. As the\nliquid migrated from the sample pad toward the absorbent pad,\nfunctionalized LNPs were captured at the test and control lines. After\na 10-min incubation, the strip was loaded into the portable\nfluorescence reader for detection of fluorescence at excitation and\nemission wavelengths of 365 and 615 nm, respectively, with the delay\ntime set at 20 \u03bcs. Excitation of the fixed LNPs produced a\nbright fluorescent zone on the membrane. The results are denoted as\nthe fluorescence peak area of the test line (At) and\ncontrol line (Ac). The\nAt/Ac ratio\n(R) was calculated to determine the\nanti-SARS-CoV-2 IgG concentration in the serum.",
            "cite_spans": [],
            "section": "Analytical Procedure and Statistical Analysis ::: Experiment",
            "ref_spans": [
                {
                    "start": 12,
                    "end": 20,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Most biochemical assays are performed in solution. In aqueous\nenvironments, the emission of lanthanide chelates is strongly\nsuppressed due to energy loss through the nonradiative activation of\nthe 5D0 state to the O\u2013H vibration of water\nmolecules.22 Thus, it is preferable to\nencapsulate lanthanide chelates in water-dispersible spheres. The\nmaximal fluorescence emission peak of LNPs was obtained at \u223c615\nnm; the peak was narrow and symmetric (Figure 2a). Dynamic light scattering analysis\nwas performed for physical characterization of LNPs before and after\nfunctionalization. The change in the size and surface zeta potential\nof LNPs (Figures 2b and 2c) indicated that the M-HIgG and RIgG antibodies\nwere successfully conjugated.",
            "cite_spans": [
                {
                    "start": 247,
                    "end": 249,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                }
            ],
            "section": "Characterization of LNPs and Functionalized LNP Probe ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 445,
                    "end": 453,
                    "mention": "Figure 2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 638,
                    "end": 647,
                    "mention": "Figures 2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 653,
                    "end": 654,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Immunoreaction time significantly influences fluorescence signals. In\nthis assay, a positive sample was measured to establish the optimal\nassay time. The At/Ac ratio\n(R) was measured every 2 min over a period of\n0\u201316 min from the start of incubation. R\nincreased rapidly over the first 4 min and reached a plateau at 10 min\n(see Figure 3). Based on this\nresult, the total assay time was determined as 10 min.",
            "cite_spans": [],
            "section": "Optimization ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 329,
                    "end": 337,
                    "mention": "Figure 3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "The reproducibility of our assay was evaluated based on intra-assay and\ninter-assay variations. Four samples were measured five times a day\nfor five consecutive days, and the coefficient of variation (CV)\nvalues were calculated. The intra-assay and inter-assay CVs were\n7.71%\u20139.69% and 11.51%\u201314.63%, respectively (see Table 1). Since the CVs were\nall <15%, we concluded that our assay is reproducible.",
            "cite_spans": [],
            "section": "Reproducibility ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "In order to define the appropriate cutoff value for our assay, we tested\n51 normal serum samples and 7 samples that were determined to be\npositive by RT-PCR. The cutoff value of R (the mean\nof normal samples plus 3 times the standard deviation) was calculated\nas 0.0666. All 7 samples that were positive by RT-PCR had an\nR value of >0.0666 (Figure\n4), indicating that the developed\nassay can detect anti-SARS-CoV-2 IgG in positive samples.",
            "cite_spans": [],
            "section": "Clinical Sample Tests ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 341,
                    "end": 349,
                    "mention": "Figure\n4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "To confirm the diagnostic accuracy of our assay, we used it to test 7\nsamples that were positive by RT-PCR and 12 that were negative but\nclinically suspect. The \u03c72 test showed that the\nP-value of the McNemar test was 1.0, and the\nvalue obtained with the kappa test was 0.890 (P <\n0.001) (see Table 2). Thus,\nthere was no statistically significant difference between the results\nobtained with our developed assay versus those obtained by RT-PCR.",
            "cite_spans": [],
            "section": "Clinical Sample Tests ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "One of the 12 clinically suspicious samples that were negative by RT-PCR\nwas found to be SARS-CoV-2 IgG positive with our assay. Unlike other\nsuspected cases, this case did not only have the fever and came with\nhigh clinical suspicion. The negative result of RT-PCR test raised\nclinical concerns about the management of this case. Base on our IgG\ntest result, the RT-PCR test result was more likely to be a false\nnegative. At present, prevention of cross-infection is very essential\nin outbreak control; timely isolation and treatment should be adopted\nfor this case.",
            "cite_spans": [],
            "section": "Clinical Sample Tests ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "The present study describes a simple and rapid LNP-based immunoassay for\ndetecting anti-SARS-CoV-2 IgG in human serum. Because there is presently no\nofficial anti-SARS-CoV-2 IgG standard available, the assay cannot be\nimproved from semiquantitative to accurate quantification. However, the\nresults of the validation experiment meet the requirements for clinical\ndiagnostic reagents. Our assay can be used to monitor the progression of\nCOVID-19, as well as responses to treatment. We expect this assay to be\nhighly useful for helping to contain the COVID-19 outbreak by allowing\ntimely diagnosis through early detection of SARS-CoV-2.",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Figure 1: Design and fabrication of the developed assay. (A) Lateral\nflow test strip. (B) Assay.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: Physical properties of LNPs and functionalized LNP probe: (A)\nabsorption and emission spectra, (B) size distribution of\nnaked and conjugated LNPs, and (C) zeta potential\ndistribution.",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: Optimization of immunoreaction time.",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Figure 4: Test results for 58 serum samples, including 51 normal and 7\npositive samples. [Symbol legend: (*) P\n< 0.05, (****) P < 0.0001 (one-way\nanalysis of variance and Fisher\u2019s least significant\ndifference test).]",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Early Transmission Dynamics in Wuhan, China, of Novel\nCoronavirus-Infected Pneumonia",
            "authors": [],
            "year": 2020,
            "venue": "N. Engl. J. Med.",
            "volume": "382",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2001316"
                ]
            }
        },
        "BIBREF1": {
            "title": "Dual FITC Lateral Flow Immunoassay for Sensitive\nDetection of Escherichia Coli O157:H7 in Food\nSamples",
            "authors": [],
            "year": 2016,
            "venue": "Biosens. Bioelectron.",
            "volume": "85",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.bios.2016.05.057"
                ]
            }
        },
        "BIBREF2": {
            "title": "Lateral Flow Assay with Near-Infrared Dye for Multiplex\nDetection",
            "authors": [],
            "year": 2013,
            "venue": "Clin. Chem.",
            "volume": "59",
            "issn": "4",
            "pages": "641-648",
            "other_ids": {
                "DOI": [
                    "10.1373/clinchem.2012.200360"
                ]
            }
        },
        "BIBREF3": {
            "title": "Simultaneous and Sensitive Detection of Dual DNA\nTargets via Quantum Dot-Assembled Amplification\nLabels",
            "authors": [],
            "year": 2016,
            "venue": "Luminescence",
            "volume": "31",
            "issn": "1",
            "pages": "281-287",
            "other_ids": {
                "DOI": [
                    "10.1002/bio.2959"
                ]
            }
        },
        "BIBREF4": {
            "title": "Rapid and Sensitive Lateral Flow Immunoassay Method for\nDetermining Alpha Fetoprotein in Serum Using Europium (III)\nChelate Microparticles-Based Lateral Flow Test\nStrips",
            "authors": [],
            "year": 2015,
            "venue": "Anal. Chim. Acta",
            "volume": "891",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.aca.2015.07.053"
                ]
            }
        },
        "BIBREF5": {
            "title": "Lanthanide Chelate-Encapsulated Polystyrene\nNanoparticles for Rapid and Quantitative Immunochromatographic\nAssay of Procalcitonin",
            "authors": [],
            "year": 2016,
            "venue": "RSC Adv.",
            "volume": "6",
            "issn": "105",
            "pages": "103463-103470",
            "other_ids": {
                "DOI": [
                    "10.1039/C6RA23816E"
                ]
            }
        },
        "BIBREF6": {
            "title": "Development and Evaluation of a Multiplexed Immunoassay\nfor Simultaneous Detection of Serum IgG Antibodies to Six Human\nCoronaviruses",
            "authors": [],
            "year": 2019,
            "venue": "Sci. Rep.",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41598-018-37747-5"
                ]
            }
        },
        "BIBREF7": {
            "title": "Potential Cross-Reactivity of Severe Acute Respiratory\nSyndrome-Associated Coronavirus (SARS-CoV) Nucleocapsid\n(N)-Based IgG ELISA Assay for Plasma Samples from HIV-1 Positive\nIntravenous Drug Users (IDUs)",
            "authors": [],
            "year": 2012,
            "venue": "Acta Med.\nIndones",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "Dynamic Changes of Serum SARS-Coronavirus IgG,\nPulmonary Function and Radiography in Patients Recovering from\nSARS after Hospital Discharge",
            "authors": [],
            "year": 2005,
            "venue": "Respir.\nRes.",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1186/1465-9921-6-5"
                ]
            }
        },
        "BIBREF9": {
            "title": "A Novel Coronavirus from Patients with Pneumonia in\nChina, 2019",
            "authors": [],
            "year": 2020,
            "venue": "N. Engl. J. Med.",
            "volume": "382",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2001017"
                ]
            }
        },
        "BIBREF10": {
            "title": "SARS: Pharmacotherapy",
            "authors": [],
            "year": 2003,
            "venue": "Respirology",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1046/j.1440-1843.2003.00525.x"
                ]
            }
        },
        "BIBREF11": {
            "title": "A Pneumonia Outbreak Associated with a New Coronavirus\nof Probable Bat Origin",
            "authors": [],
            "year": 2020,
            "venue": "Nature",
            "volume": "579",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/s41586-020-2012-7"
                ]
            }
        },
        "BIBREF12": {
            "title": "Ultrasensitive Sensor Using Quantum Dots-Doped\nPolystyrene Nanospheres for Clinical Diagnostics of Low-Volume\nSerum Samples",
            "authors": [],
            "year": 2019,
            "venue": "Anal. Chem.",
            "volume": "91",
            "issn": "9",
            "pages": "5777-5785",
            "other_ids": {
                "DOI": [
                    "10.1021/acs.analchem.9b00010"
                ]
            }
        },
        "BIBREF13": {
            "title": "Simultaneous Quantitation of Cytokeratin-19 Fragment\nand Carcinoembryonic Antigen in Human Serum via Quantum\nDot-Doped Nanoparticles",
            "authors": [],
            "year": 2017,
            "venue": "Biosens. Bioelectron.",
            "volume": "91",
            "issn": "",
            "pages": "60-65",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bios.2016.12.036"
                ]
            }
        },
        "BIBREF14": {
            "title": "Polystyrene Latex Particles Containing Europium\nComplexes Prepared by Miniemulsion Polymerization Using Bovine\nSerum Albumin as a Surfactant for Biochemical\nDiagnosis",
            "authors": [],
            "year": 2016,
            "venue": "Colloids Surf., B",
            "volume": "145",
            "issn": "",
            "pages": "152-159",
            "other_ids": {
                "DOI": [
                    "10.1016/j.colsurfb.2016.04.055"
                ]
            }
        },
        "BIBREF15": {
            "title": "Clinical Characteristics of Coronavirus Disease 2019 in\nChina",
            "authors": [],
            "year": 2020,
            "venue": "N. Engl. J. Med.",
            "volume": "382",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2002032"
                ]
            }
        },
        "BIBREF16": {
            "title": "Epidemiological and Clinical Features of the 2019 Novel\nCoronavirus Outbreak in China",
            "authors": [],
            "year": 2020,
            "venue": "medRxiv",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1101/2020.02.10.20021675"
                ]
            }
        },
        "BIBREF17": {
            "title": "Molecular Diagnosis of a Novel Coronavirus (2019-NCoV)\nCausing an Outbreak of Pneumonia",
            "authors": [],
            "year": 2020,
            "venue": "Clin. Chem.",
            "volume": "66",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1093/clinchem/hvaa029"
                ]
            }
        },
        "BIBREF18": {
            "title": "Clinical Diagnosis of 8274 Samples with 2019-Novel\nCoronavirus in Wuhan",
            "authors": [],
            "year": 2020,
            "venue": "medRxiv",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1101/2020.02.12.20022327"
                ]
            }
        },
        "BIBREF19": {
            "title": "Optimizing Diagnostic Strategy for Novel Coronavirus\nPneumonia, a Multi-Center Study in Eastern\nChina",
            "authors": [],
            "year": 2020,
            "venue": "medRxiv",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1101/2020.02.13.20022673"
                ]
            }
        },
        "BIBREF20": {
            "title": "Chest CT for Typical 2019-NCoV Pneumonia: Relationship\nto Negative RT-PCR Testing",
            "authors": [],
            "year": 2020,
            "venue": "Radiology",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1148/radiol.2020200343"
                ]
            }
        },
        "BIBREF21": {
            "title": "Development of a Lateral Flow Immunochromatographic\nAssay for Rapid Detection of Mycoplasma Pneumoniae-Specific IgM\nin Human Serum Specimens",
            "authors": [],
            "year": 2016,
            "venue": "J. Microbiol. Methods",
            "volume": "124",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.mimet.2016.03.006"
                ]
            }
        }
    }
}